Is it time to convert the frequency of radiotherapy in small-cell lung cancer?

Lancet Oncol. 2017 Oct;18(10):e555. doi: 10.1016/S1470-2045(17)30620-4.

Authors

Chukwuka Eze¹, Olarn Roengvoraphoj², Maurice Dantes², Farkhad Manapov²

Affiliations

¹ Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany; Comprehensive Pneumology Center Munich (CPC-M), Member of the German Center for Lung Research (DZL), Munich, Germany. Electronic address: [email protected].
² Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany; Comprehensive Pneumology Center Munich (CPC-M), Member of the German Center for Lung Research (DZL), Munich, Germany.

PMID: 28971814
DOI: 10.1016/S1470-2045(17)30620-4

No abstract available

Publication types

Letter
Comment

MeSH terms

Carcinoma, Non-Small-Cell Lung / radiotherapy*
Humans
Lung Neoplasms / radiotherapy
Radiotherapy Dosage
Small Cell Lung Carcinoma / radiotherapy*